San Ramon, CA-September 30, 2009
Nextrials, Inc.
, has upgraded its electronic data capture and clinical trial management platform, Prism. In addition to its new user interface, Prism now offers expanded functionality and interoperability with electronic health records from multiple vendors.
Prism users will see differences to its start page, where researchers can now evaluate project data from multiple studies organized into modules that can be collapsed and expanded for review. The “at a glance” statistics roll-up bar is intended to provide users with fast facts, such as enrollment status and data quality metrics. And with Prism’s newly streamlined structure, pop-up windows have been reduced in favor of intuitive layers within the browser.
A significant change to Prism is its interoperability with data platforms more traditionally found within the healthcare environment for creating and managing electronic medical records. This gives life science companies many more options for implementing studies using patients and sites. Also, major incentives included in the American Recovery and Reinvestment Act (ARRA) will further promote the adoption of electronic medical records.
Nextrials expanded Prism’s report generation functionality earlier in the year to give users more powerful data mining capabilities. This ad hoc reporting feature has been further enhanced so that customers can now share reports with others, more easily monitor study progress and even drill down to analyze underlying data.
Prism 3.0 will continue to support mobile access to data via the Apple iPhone. Nextrials expects Prism 3.0 to be in general availability before the end of the year. However, attendees at the 2009 Society for Clinical Data Management Annual Conference, being held at the Westin Seattle (WA) Hotel October 4-6, can get a first look at Nextrials’ Prism 3.0 in booth #301 and #303.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.